Retatrutide decreased HbA1c by 2.02% in a phase II clinical trial, while dulaglutide 1.5 mg decreased HbA1c by 1.14% and a placebo decreased it by 0.01% [109]
Integrated multi-omics approaches including transcriptomics, genomics, proteomics, metabolomics, and phenomics are transforming our understanding of resilience by revealing interactions among genes, proteins, and metabolites (Yang et al
pH Balance & Toxin Avoidance Using alkalizing strategies (bicarbonate, diet, hydration) to prevent metabolic acidosis and avoiding nephrotoxic compounds (heavy metals, glyphosate, processed foods)
Signal 11 , eaas9332 (2018)
For more scientific information on BPC-157's healing properties, you can review this research published in PubMed